Paul V. Goode's most recent trade in GlucoTrack Inc was a trade of 42 Common Stock, par value $0.001 per share done . Disclosure was reported to the exchange on March 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 25 Mar 2025 | 42 | 339 | - | - | Common Stock, par value $0.001 per share | |
| GlucoTrack Inc | Paul V. Goode | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Jul 2024 | 42,000 | 42,000 | - | - | Warrants to Purchase Common Stock | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | 14 Jun 2024 | 15,435 | 18,989 | - | 0 | Common Stock, par value $0.001 per share | ||
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 3,277 | 3,277 | - | - | Stock option (right to buy) | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Jun 2024 | 2,100 | 2,100 | - | - | Warrants to Purchase Common Stock | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 1,500 | 3,554 | - | - | Common Stock, par value $0.001 per share | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 796 | 796 | - | - | Series A Common Warrant | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | 14 Jun 2024 | 796 | 2,054 | - | 31.2 | 24,835 | Common Stock, par value $0.001 per share | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 796 | 796 | - | - | Series B Common Warrant | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | 14 Jun 2024 | 796 | 0 | - | - | Series B Common Warrant |